-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNDAX ANNOUNCES PUBLICATION OF REVUMENIB DATA FROM THE BEAT AML TRIAL IN THE JOURNAL OF CLINICAL ONCOLOGY AND SIMULTANEOUS PRESENTATION AT EHA 2025

Reuters·06/12/2025 16:02:01

Please log in to view news